Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-26 @ 4:16 AM
Study NCT ID:
NCT02994927
Status:
COMPLETED
Last Update Posted:
2025-03-24
First Post:
2016-12-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-11
First Submit QC Date:
None
Study First Post Date:
2016-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-05-19
Results First Submit QC Date:
None
Results First Post Date:
2022-09-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-24
Last Update Post Date Type:
ACTUAL